Legal status · Canada
Is Idebenone legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Idebenone is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 5 human studies are cited on its profile.
Idebenone in Canada at a glance
| Classification | Not approved |
|---|---|
| Note | No Health Canada authorisation located; sold in cosmetic antioxidant products. |
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 5 of 6 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Idebenone profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing Idebenone is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What Idebenone is
Authorised in the European Union for one rare mitochondrial optic neuropathy, granted under exceptional circumstances because the normal evidence standard was not met. The randomised trial that supported it missed its primary endpoint, and the trials in Alzheimer's disease and Friedreich ataxia were negative.
Idebenone is three separate products wearing one name, and they should not be read as supporting each other. The medicine.
Mechanism: A short-chain benzoquinone that can accept electrons from cytosolic NAD(P)H quinone dehydrogenase 1 and deliver them to complex III, bypassing a defective complex I. That is a coherent rationale for a disease caused by complex I mutations, which is what Leber hereditary optic neuropathy is, and it is why the drug found its indication there rather than in general antioxidant use.
Regulatory history: Not FDA approved for any indication. Authorised in the European Union as Raxone for Leber hereditary optic neuropathy since September 2015, under exceptional circumstances. Separately sold in topical skincare and in oral nootropic supplements, neither of which is an approved use.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Idebenone at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Idebenone in other countries
United States
Not approvedNot approved; sold in cosmetics and supplements
Is Idebenone legal in the United States?United Kingdom
Not approvedPrescription medicine in the European Union (Raxone)
Is Idebenone legal in the United Kingdom?Australia
Not approvedNot registered
Is Idebenone legal in Australia?Frequently asked questions
Is Idebenone legal in Canada?
No. Idebenone is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 5 human studies are cited on its profile. Note: No Health Canada authorisation located; sold in cosmetic antioxidant products.
Can I buy Idebenone in Canada?
No approved product exists to buy. In Canada Idebenone is classified as "Not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: No Health Canada authorisation located; sold in cosmetic antioxidant products.
Is Idebenone Health Canada approved?
No. In Canada Idebenone is classified as "Not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Not FDA approved for any indication. Authorised in the European Union as Raxone for Leber hereditary optic neuropathy since September 2015, under exceptional circumstances. Separately sold in topical skincare and in oral nootropic supplements, neither of which is an approved use.. On the evidence, 5 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Idebenone live on its compound profile.
Idebenone profileThis page is general information about the regulatory status of Idebenone in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.